Novartis buys a preclinical biotech and its RNA drug technology

Novartis buys a preclinical biotech and its RNA drug technology

Submitted by admin on July 17, 2023 - 7:07pm
Source: 
BioPharma Dive
News Tags: 
Novartis
DTxPharma
siRNA
M&A
Headline: 
Novartis buys a preclinical biotech and its RNA drug technology
snippet: 

The Swiss pharmaceutical company will pay $500 million to acquire DTx Pharma, which specializes in siRNA therapies for neurological diseases.

Do Not Allow Advertisers to Use My Personal information